Statistics for Can serious adverse event rates be used as a metric of trial representativeness for pharmacological interventions? Glucagon-like peptide-1 receptor agonist trials as an exemplar
Total visits
| views | |
|---|---|
| Can serious adverse event rates be used as a metric of trial representativeness for pharmacological interventions? Glucagon-like peptide-1 receptor agonist trials as an exemplar | 16 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 9 |
| March 2025 | 0 |
| April 2025 | 7 |
File Visits
| views | |
|---|---|
| ٍSACM-Dissertation.pdf | 2 |
| 44d13fc2-4430-469b-9de2-0adb815a7910 | 1 |